Evidence map›Paper›PMID 35059086›Full record

ArticleJournal of hematology2021

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.

Anu Partanen, Outi Kuittinen, Antti Turunen, Jaakko Valtola, Marja Pyorala, Hanne Kuitunen, Kaija Vasala, Taru Kuittinen, Pentti Mantymaa, Jukka Pelkonen and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Anu PartanenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Outi KuittinenInstitute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Antti TurunenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Jaakko ValtolaDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Marja PyoralaDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Hanne KuitunenDepartment of Oncology, Oulu University Hospital, Oulu, Finland.
Kaija VasalaDepartment of Oncology, Central Hospital of Central Finland, Jyvaskyla, Finland.
Taru KuittinenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Pentti MantymaaEastern Finland Laboratory Centre, Kuopio, Finland.
Jukka PelkonenEastern Finland Laboratory Centre, Kuopio, Finland.
Esa JantunenDepartment of Medicine, Kuopio University Hospital, Kuopio, Finland.
Ville VarmavuoDepartment of Medicine, Kymenlaakso Central Hospital, Kotka, Finland.
Kuopio University Hospital · FIEastern Finland Laboratory Center · FIKymenlaakson keskussairaala · FIOulu University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutologous stem cell transplantation (auto-SCT) is a treatment option for patients with primary central nervous system lymphoma (PCNSL).

methodsIn this prospective multicenter study, the effects of blood graft cellular content on hematologic recovery and outcome were analyzed in 17 PCNSL patients receiving auto-SCT upfront.

resultsThe infused viable CD34

conclusionThe cellular composition of infused graft seems to impact on the hematologic recovery and PFS post-transplant. Further studies are needed to verify the optimal autograft cellular content in PCNSL.

Indexed as

Autograft cellular compositionAutologous stem cell transplantationCD34+ cell mobilizationOutcomePrimary central nervous lymphoma

Identifiers

PMID35059086
PMCPMC8734492
OpenAlexW4200291830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.